Paul Mellett
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Enanta Pharmaceuticals Inc (ENTA)
Proxy statement
Current -
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Enanta Pharmaceuticals Inc (ENTA) | Chief Financial and Administrative Officer | $486,325 | $1,136,539 |
| 2023 | Enanta Pharmaceuticals Inc (ENTA) | Chief Financial and Administrative Officer | $453,975 | $2,375,714 |
| 2022 | Enanta Pharmaceuticals Inc (ENTA) | Chief Financial and Administrative Officer | $440,381 | $1,887,570 |
| 2021 | Enanta Pharmaceuticals Inc (ENTA) | Chief Financial and Administrative Officer | $440,381 | $1,887,570 |
| 2020 | Enanta Pharmaceuticals Inc (ENTA) | Senior Vice President, Finance & Administration and Chief Financial Officer | $425,894 | $1,781,843 |
| 2019 | Enanta Pharmaceuticals Inc (ENTA) | Senior Vice President, Finance & Administration, Chief Financial Officer | $411,775 | $1,531,563 |
| 2018 | Enanta Pharmaceuticals Inc (ENTA) | Senior Vice President, Finance & Administration and Chief Financial Officer | $370,728 | $1,607,853 |
| 2017 | Enanta Pharmaceuticals Inc (ENTA) | Senior Vice President, Finance & Administration and Chief Financial Officer | $370,728 | $1,607,853 |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.